Inspections, Compliance, Enforcement, and Criminal Investigations
Christian Hospital Northeast-Northwest - Close Out Letter 5/7/12
| Public Health Service Food and Drug Administration |
| Center for Biologics Evaluation and Research 1401 Rockville Pike Rockville, MD 20852-1448 |
May 7, 2012
Ronald B. McMullen, President
Christian Hospital Northeast-Northwest
11133 Dunn Road
St. Louis, Missouri 63136
Dear Mr. McMullen:
The Food and Drug Administration has completed an evaluation of your corrective actions in response to our Warning Letter CBER -12-02 dated March 27, 2012. Based on our evaluation, it appears that you have addressed the violations contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.
This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.
Sincerely,
/s/
Mary A. Malarkey, Director
Office of Compliance and Biologics Quality
Center for Biologics Evaluation and Research
cc:
John Thorsky, District Director
Kansas District, HFR- SW 300
Food and Drug Administration
11510 West 80th Street
Lenexa, Kansas 66214





Department of Health and Human Services

